Zometa Concentrate - API Insight 2018 - ResearchAndMarkets.com

December 21, 2018

DUBLIN--(BUSINESS WIRE)--Dec 21, 2018--The “Zometa Concentrate - API Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Zometa Concentrate - API Insight, 2018 report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Zometa Concentrate. The report also highlights the patent details of Zometa Concentrate.

Reasons to Purchase this report:Evaluate the marketing status of Zometa Concentrate to exploit opportunities for generic Zometa Concentrate development opportunitiesDesign effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Zometa ConcentrateAPI intelligence over Zometa Concentrate and gaining primary intelligence over Active Ingredient manufacturers by countryMake more informed business decisions from insightful and in-depth analysis of the Zometa Concentrate’s performance

Key Topics Covered:

1. Zometa Concentrate Overview

2. Zometa Concentrate Global Sales Assessment

Zometa Concentrate Historical Global SalesZometa Concentrate Forecasted Global Sales

3. Product Description

Mechanism of ActionPharmacodynamic PropertiesPharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

Active Pharmaceutical Ingredient (API) Manufacturers by CountryActive Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/2p8n5c/zometa?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181221005290/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs,Endocrine and Metabolic Disorders Drugs,Musculoskeletal Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/21/2018 09:44 AM/DISC: 12/21/2018 09:44 AM


Update hourly